15 insiders reported 183 Form 4 transactions for Revolution Medicines, Inc. (RVMD) over the past 18 months (most recent 2026-07-01). Recent activity: Patel Sushil (Director) Buy 2,955 shares, Patel Sushil (Director) Sell 300 shares, Patel Sushil (Director) Sell 900 shares, Patel Sushil (Director) Sell 1,100 shares, Patel Sushil (Director) Sell 858 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | Patel Sushil | Director | Buy | 2,955 | $110,931 |
| 2026-07-01 | Patel Sushil | Director | Sell | 300 | $54,952 |
| 2026-07-01 | Patel Sushil | Director | Sell | 900 | $166,128 |
| 2026-07-01 | Patel Sushil | Director | Sell | 1,100 | $204,489 |
| 2026-07-01 | Patel Sushil | Director | Sell | 858 | $160,374 |
| 2026-07-01 | Patel Sushil | Director | Sell | 300 | $56,348 |
| 2026-07-01 | Patel Sushil | Director | Sell | 100 | $18,857 |
| 2026-07-01 | Patel Sushil | Director | Sell | 600 | $114,327 |
| 2026-07-01 | Patel Sushil | Director | Sell | 541 | $103,800 |
| 2026-07-01 | Patel Sushil | Director | Sell | 881 | $169,693 |
| 2026-06-26 | Anders Jack | Chief Financial Officer | Sell | 9,496 | $1.6M |
| 2026-06-26 | Anders Jack | Chief Financial Officer | Sell | 4,553 | $761,922 |
| 2026-06-26 | Anders Jack | Chief Financial Officer | Buy | 20,000 | $371,200 |
| 2026-06-26 | Anders Jack | Chief Financial Officer | Sell | 5,651 | $956,398 |
| 2026-06-26 | Anders Jack | Chief Financial Officer | Sell | 300 | $51,096 |
| 2026-06-23 | Kim Lorence H. | Director | Buy | 1,191 | $0 |
| 2026-06-23 | Borellini Flavia | Director | Buy | 1,191 | $0 |
| 2026-06-23 | Patel Sushil | Director | Buy | 1,191 | $0 |
| 2026-06-23 | Clyburn Frank | Director | Buy | 1,191 | $0 |
| 2026-06-23 | ANDERSON ELIZABETH M | Director | Buy | 1,191 | $0 |
| 2026-06-23 | Borisy Alexis | Director | Buy | 1,191 | $0 |
| 2026-06-23 | Horning Sandra | Director | Buy | 1,191 | $0 |
| 2026-06-18 | GOLDSMITH MARK A | See Remarks | Sell | 10,020 | $1.6M |
| 2026-06-18 | Kelsey Stephen Michael | See Remarks | Sell | 4,175 | $651,798 |
| 2026-06-18 | Anders Jack | Chief Financial Officer | Sell | 2,722 | $424,956 |
Source: SEC Form 4 filings · as of 2026-07-01